Home » Topics » Biomarkers, BioWorld Science

Biomarkers, BioWorld Science
RSS

ERYtech and M.D. Anderson Cancer Center to develop biomarker assay for personalized treatment

Feb. 17, 2010

Compugen discovers genetic biomarker for predisposition to type 2 diabetes

Nov. 10, 2009

Thermo Fisher Scientific launches new biomarker test for heart attack

Nov. 3, 2009

BioPorto reports technical data of NGAL diagnostic test for acute kidney injury

Nov. 3, 2009

Psynova Neurotech and RBM identify diagnostic biomarkers for schizophrenia

Oct. 27, 2009

Bone formation/resorption biomarkers predict response to Re-186 HEDP therapy in prostate cancer

Oct. 27, 2009

Epigenomics initiates testing of mSEPT9 in plasma samples collected in PRESEPT study

Oct. 13, 2009

Epigenomics launches Epi proColon blood test for early detection of colorectal cancer

Oct. 9, 2009

Quest Diagnostics initiates DNA testing for Plavix response in coronary heart patients

Oct. 9, 2009

New CVDefine biomarker kit for cardiovascular disease available in North America

Oct. 1, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...